Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 119385
Published online Sep 20, 2026. doi: 10.5662/wjm.119385
Published online Sep 20, 2026. doi: 10.5662/wjm.119385
Table 4 Analysis of the quality of evidence by GRADE
| Outcome | Studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | GRADE |
| ED | 7 | Trial = 1, retrospective = 4, pilot study = 1 | Serious | Serious (I2 = 90%) | Not serious | Not serious | None | Very low |
| TT | 6 | Trial = 1, retrospective = 3, pilot study = 1 | Serious | Serious (I2 = 99%) | Not serious | Not serious | None | Very low |
| FT | 5 | Trial = 1, retrospective = 3, pilot study = 1 | Serious | Serious (I2 = 86%) | Not serious | Not serious | None | Very low |
| SHBG | 6 | Trial = 1, retrospective = 4, pilot study = 1 | Serious | Serious (I2 = 99%) | Not serious | Not serious | None | Very low |
| LH | 5 | Trial = 1, retrospective = 3, pilot study = 1 | Serious | Serious (I2 = 91%) | Not serious | Not serious | None | Very low |
| FSH | 5 | Trial = 1, retrospective = 3, pilot study = 1 | Serious | Serious (I2 = 91%) | Not serious | Not serious | None | Very low |
- Citation: Mirghani HO, AlQurashi AM. Glucagon-like receptor-1 agonists and impotence: A meta-analysis. World J Methodol 2026; 16(3): 119385
- URL: https://www.wjgnet.com/2222-0682/full/v16/i3/119385.htm
- DOI: https://dx.doi.org/10.5662/wjm.119385